{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:45Z","timestamp":1761894225092,"version":"3.32.0"},"reference-count":86,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p>O termo neoplasia end\u00f3crina m\u00faltipla tipo 2 (NEM 2) foi sugerido em 1968, por Steiner e cols., para diferenciar a s\u00edndrome cl\u00ednica caracterizada pela presen\u00e7a de carcinoma medular de tire\u00f3ide (CMT), feocromocitoma e hiperparatireoidismo, ent\u00e3o denominada s\u00edndrome de Sipple, da s\u00edndrome de Wermer ou NEM tipo 1, que acomete as gl\u00e2ndulas paratire\u00f3ides, p\u00e2ncreas e hip\u00f3fise. Sizemore e cols. (1974) complementaram a diferencia\u00e7\u00e3o atrav\u00e9s da classifica\u00e7\u00e3o da NEM 2 em 2 subgupos: pacientes com CMT, feocromocitoma, hiperparatireoidismo e apar\u00eancia normal (NEM 2A) e pacientes sem acometimento das paratire\u00f3ides e fen\u00f3tipo caracterizado por ganglioneuromatose intestinal e h\u00e1bitos marfan\u00f3ides (NEM 2B). CMT \u00e9 usualmente o primeiro tumor a ser diagnosticado. O diagn\u00f3stico do CMT determina que seja avaliada a extens\u00e3o da doen\u00e7a e rastreamento do feocromocitoma e hiperparatireoidismo. O diagn\u00f3stico de CMT espor\u00e1dico ou heredit\u00e1rio \u00e9 realizado atrav\u00e9s da an\u00e1lise molecular do proto-oncogene RET. Neste artigo s\u00e3o discutidos os aspectos fisiopatol\u00f3gicos, as anormalidades gen\u00e9ticas e os aspectos cl\u00ednicos da NEM 2. A abordagem diagn\u00f3stica e terap\u00eautica nos indiv\u00edduos afetados, carreadores assintom\u00e1ticos e familiares em risco tamb\u00e9m s\u00e3o discutidos. Os avan\u00e7os relacionados ao rastreamento gen\u00e9tico e interven\u00e7\u00e3o precoce permitiram uma melhoria no progn\u00f3stico a longo prazo. No entanto, ainda n\u00e3o dispomos de tratamento eficaz para doen\u00e7a metast\u00e1tica.<\/jats:p>","DOI":"10.1590\/s0004-27302005000500013","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T14:05:59Z","timestamp":1139580359000},"page":"725-734","source":"Crossref","is-referenced-by-count":9,"title":["Neoplasia end\u00f3crina m\u00faltipla tipo 2"],"prefix":"10.1590","volume":"49","author":[{"given":"Ana Luiza","family":"Maia","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Luiz","family":"Gross","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia Khaled","family":"Pu\u00f1ales","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"47","key":"ref1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","article-title":"Study of kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing\u2019s disease: multiple endocrine neoplasia, type 2","author":"Steiner AL","year":"1968","journal-title":"Medicine (Baltimore)","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7974","issn-type":"print"},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects adenomatosis of endocrine glands","author":"Wermer P.","year":"1954","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"issue":"59","key":"ref3","first-page":"1736","article-title":"The phenotypes associated with RET mutations in the multiple endocrine neoplasia type 2 syndromes","author":"Ponder BA.","year":"1999","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"276","key":"ref4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutation and disease phenotype in multiple endocrine neoplasia type 2","author":"Eng C","year":"1996","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"238","key":"ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"International RET mutation consortium. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of international RET mutation consortium","author":"Mulligan LM","year":"1995","journal-title":"J Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0954-6820","issn-type":"print"},{"issue":"103","key":"ref6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9343(97)00024-7","article-title":"Advances and controversies in the diagnosis and management of medullary thyroid carcinoma","author":"Heshmati HM","year":"1997","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"issue":"86","key":"ref7","first-page":"1104","article-title":"Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties","author":"Machens A","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"38","key":"ref8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1993.tb00350.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2A: survey of 100 cases","author":"Casanova S","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"111","key":"ref9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-111-10-802","article-title":"Multiple endocrine neoplasia type 2 associated with cutaneous lichen amyloidosis","author":"Gagel R","year":"1989","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"issue":"30","key":"ref10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2265.1989.tb03727.x","article-title":"Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple\u2019s syndrome)","author":"Nunziata V","year":"1989","journal-title":"Clin Endocrinol (Oxf)","ISSN":"https:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"issue":"335","key":"ref11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM199609263351307","article-title":"The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirsprung\u2019s disease","author":"Eng C","year":"1996","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2 B and related sporadic tumors","author":"Eng C","year":"1994","journal-title":"Hum Mol Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0964-6906","issn-type":"print"},{"issue":"38","key":"ref13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1258\/0004563011900614","article-title":"Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement","author":"Lips CJM","year":"2001","journal-title":"Ann Clin Biochem","ISSN":"https:\/\/id.crossref.org\/issn\/0004-5632","issn-type":"print"},{"issue":"331","key":"ref14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","article-title":"Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A","author":"Lips CJM","year":"1994","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"2","key":"ref15","first-page":"247","article-title":"Localization of the gene for multiple endocrine neoplasia type 2A to 480 kb region in chromosome band 10q112","author":"Mole SE","year":"1987","journal-title":"Hum Mol Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0964-6906","issn-type":"print"},{"issue":"3","key":"ref16","first-page":"571","article-title":"Cloning and expression of the RET proto-oncogene encoding a tyrosine-kinase with two potential transmembrane domain","author":"Takahashi M","year":"1988","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"8","key":"ref17","first-page":"2575","article-title":"Mulligan LM. Structural analysis of the human RET proto-oncogene using exon trapping","author":"Kwok J","year":"1993","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"85","key":"ref18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","article-title":"GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF","author":"Jing S","year":"1996","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"issue":"381","key":"ref19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/381789a0","article-title":"GNDF signaling through the RET receptor tyrosine kinase","author":"Durbec P","year":"1996","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"963","key":"ref20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2002.tb04102.x","article-title":"Molecular mechanism of RET activation in human cancer","author":"Santoro M","year":"2002","journal-title":"Ann NY Acad Science"},{"issue":"22","key":"ref21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/BF03343650","article-title":"Molecular mechanisms of RET activation in human neoplasia","author":"Santoro M","year":"1999","journal-title":"J Endocrinol Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"issue":"267","key":"ref22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B","author":"Santoro M","year":"1995","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutation in the RET proto-oncogene are associated with MEN 2A and CMTF","author":"Donis-Keller H","year":"1993","journal-title":"Hum Mol Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0964-6906","issn-type":"print"},{"issue":"17","key":"ref24","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","article-title":"Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines","author":"Chappuis-Flament S","year":"1998","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"79","key":"ref25","first-page":"590","article-title":"Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A","author":"Quadro L","year":"1994","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"56","key":"ref26","first-page":"2167","article-title":"Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma","author":"Eng C","year":"1996","journal-title":"Cancer Research","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"82","key":"ref27","first-page":"4176","article-title":"A novel point mutation in the intracellular domain of RET proto-oncogene in a family with medullary thyroid carcinoma","author":"Hofstra RMW","year":"1997","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"82","key":"ref28","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jcem.82.11.4508","article-title":"Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation","author":"Gimm O","year":"1997","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"88","key":"ref29","first-page":"4862","article-title":"A novel germ-line point mutation in RET exon 8 (gly533cys) in a large kindred with familial medullary thyroid carcinoma","author":"Silva AMA","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"94","key":"ref30","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.94.7.3330","article-title":"Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation","author":"Michiels FM","year":"1997","journal-title":"Proc Natl Acad Sci USA","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/sj.onc.1203648","article-title":"Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice","author":"Acton DS","year":"2000","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"60","key":"ref32","first-page":"5254","article-title":"Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation","author":"Kawai K","year":"2000","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"19","key":"ref33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/emboj\/19.4.612","article-title":"C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B","author":"Smith-Hicks CL","year":"2000","journal-title":"EMBO J","ISSN":"https:\/\/id.crossref.org\/issn\/0261-4189","issn-type":"print"},{"issue":"86","key":"ref34","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.86.8.7767","article-title":"The French calcitonin tumors study group (GETC). Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients","author":"Niccoli-Sire P","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"48","key":"ref35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S0004-27302004000100015","article-title":"Carcinoma medular de tire\u00f3ide: Aspectos cl\u00ednico-oncol\u00f3gicos e terap\u00eauticos","author":"Pu\u00f1ales MK","year":"2004","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"46","key":"ref36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1590\/S0004-27302002000600006","article-title":"Rastreamento gen\u00e9tico do carcinoma medular de tire\u00f3ide: identifica\u00e7\u00e3o de muta\u00e7\u00f5es no proto-oncogene RET","author":"Pu\u00f1ales MK","year":"2002","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"44","key":"ref37","first-page":"TL72, S195","article-title":"Neoplasia end\u00f3crina m\u00faltipla tipo 2A (NEM 2A). Estudo molecular e bioqu\u00edmico","author":"Vieira AEF","year":"2000","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"44","key":"ref38","first-page":"TQ12, S168","article-title":"Rastreamento gen\u00e9tico em fam\u00edlias com neoplasia end\u00f3crina m\u00faltipla tipo 2 (NEM 2)","author":"Nunes AB","year":"2000","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"128","key":"ref39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","article-title":"Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M .(GTG\u00c6ATG) mutation","author":"Feldman GL","year":"2000","journal-title":"Surgery","ISSN":"https:\/\/id.crossref.org\/issn\/0039-6060","issn-type":"print"},{"issue":"87","key":"ref40","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jcem.87.4.8403","article-title":"Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804","author":"Lombardo F","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"88","key":"ref41","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2002-021422","article-title":"RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome","author":"Pu\u00f1ales MK","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"16","key":"ref42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"and the European Multiple Endocrine Neoplasia (EUROMEN) Study Group: Early malignant progression of hereditary medullary thyroid cancer","author":"Machens A","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"60","key":"ref43","first-page":"6223","article-title":"Lichtenauer, Mannan P, et al. Duplication of the mutant RET allele in trissony 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytoma","author":"Huang SC","year":"2000","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"88","key":"ref44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/jc.2002-021254","article-title":"Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma","author":"Huang SC","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"19","key":"ref45","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1200\/JCO.2001.19.5.1374","article-title":"Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients","author":"Wiench M","year":"2001","journal-title":"J Clinical Oncology"},{"issue":"63","key":"ref46","first-page":"1814","article-title":"Polymorphisms G691S\/S904S of RET as genetic modifiers of MEN 2A","author":"Robledo M","year":"2003","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"253","key":"ref47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2796.2003.01166.x","article-title":"Surgical treatment of medullary thyroid carcinoma","author":"Cohen MS","year":"2003","journal-title":"J Intern Medicine"},{"issue":"257","key":"ref48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","article-title":"Advances in the management of hereditary medullary thyroid carcer","author":"Machens A","year":"2005","journal-title":"J Int Med","ISSN":"https:\/\/id.crossref.org\/issn\/0241-0109","issn-type":"print"},{"issue":"88","key":"ref49","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","article-title":"Rationale for central and bilateral lynph node dissection in sporadic and hereditary medullary thyroid cancer","author":"Scollo C","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/107327480000700305","article-title":"Medullary carcinoma of the thyroid","author":"Randolph GW","year":"2000","journal-title":"Cancer Control","ISSN":"https:\/\/id.crossref.org\/issn\/1073-2748","issn-type":"print"},{"issue":"86","key":"ref51","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","author":"Brandi ML","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"349","key":"ref52","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMe038148","article-title":"Lessons learned from the management of a rare genetic cancer","author":"Cote GJ","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"94","key":"ref53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/cncr.10228","article-title":"Very early detection of RET proto-ongogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children","author":"Sanso GE","year":"2002","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"issue":"243","key":"ref54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2796.1998.00333.x","article-title":"Surgical management of patients with persistent or recurrent medullary thyroid cancer","author":"Moley JF","year":"1998","journal-title":"J Intern Medicine"},{"issue":"89","key":"ref55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/1097-0142(20000815)89:4<863::AID-CNCR19>3.0.CO;2-Z","article-title":"Is thyroidectomy necessary in RET mutations carriers of familial medullary thyroid carcinoma syndrome?","author":"Hansen HS","year":"2000","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"issue":"238","key":"ref56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"and the EuroMEN Study Group. Pheochromocytoma in multiple endocrine neoplasia type 2: European study","author":"Modigliani E","year":"1995","journal-title":"J Intern Medicine"},{"issue":"134","key":"ref57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Goldstein DS: Recent advances in genetics, diagnosis, localization and treatment of pheochromocytoma","author":"Pacak K","year":"2001","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"issue":"57","key":"ref58","first-page":"197","article-title":"Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type 2A","author":"Porpiglia F","year":"2002","journal-title":"Horm Res","ISSN":"https:\/\/id.crossref.org\/issn\/0301-0163","issn-type":"print"},{"issue":"238","key":"ref59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","author":"Raue F","year":"1995","journal-title":"J Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0954-6820","issn-type":"print"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.0.0080135","article-title":"Treatment of medullary thyroid carcinoma update","author":"Orlandi F","year":"2001","journal-title":"Endocr Relat Cancer"},{"issue":"14","key":"ref61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF03346846","article-title":"Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer","author":"De Besi P","year":"1991","journal-title":"J Endocrinol Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"issue":"71","key":"ref62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/bjc.1995.73","article-title":"Group d\u2019 Etude des Tumeurs \u00e0 Calcitonine (GETC). Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine","author":"Schlumberger M","year":"1995","journal-title":"Br J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0007-0920","issn-type":"print"},{"issue":"73","key":"ref63","first-page":"432","article-title":"Treatment of advanced medullary thyroid carcinoma with combination cyclophosphamide and dacarbazine","author":"Wu LT","year":"1994","journal-title":"Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"issue":"35","key":"ref64","first-page":"535","article-title":"Indications for percutaneaus radiotherapy in carcinoma of the thyroid gland. Freiburg consensus","author":"Reinhardt M","year":"1995","journal-title":"Radiologie","ISSN":"https:\/\/id.crossref.org\/issn\/0720-3322","issn-type":"print"},{"issue":"6","key":"ref65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1996.6.305","article-title":"Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control","author":"Brierly J","year":"1996","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"20","key":"ref66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0212-6982(01)72011-3","article-title":"Avances terap\u00e9uticos de medicina nuclear en oncolog\u00eda","author":"Olmos RAV","year":"2001","journal-title":"Rev Esp Med Nuclear"},{"issue":"41","key":"ref67","first-page":"93","article-title":"Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(Ab)2 anti-carcinoembryonic AHS","author":"Juweid ME","year":"2000","journal-title":"J Nucl Med","ISSN":"https:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"issue":"143","key":"ref68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1430447","article-title":"New perpectives for gene therapy in endocrinology","author":"Barzon L","year":"2000","journal-title":"Eur J Endocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"issue":"143","key":"ref69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1430015","article-title":"Innovative strategies for the treatment of thyroid cancer","author":"Schmutzler C","year":"2000","journal-title":"Eur J Endocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"issue":"81","key":"ref70","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-003-0455-6","article-title":"Gene therapeutic approaches for medullary thyroid carcinoma treatment","author":"Drosten M","year":"2003","journal-title":"J Mol Med","ISSN":"https:\/\/id.crossref.org\/issn\/0377-046X","issn-type":"print"},{"key":"ref71","first-page":"s40","article-title":"Abstract","author":"Santoro M","year":"2005","journal-title":"ENDO","ISSN":"https:\/\/id.crossref.org\/issn\/0294-1813","issn-type":"print"},{"issue":"83","key":"ref72","first-page":"4210","article-title":"Mutation of the RET proto-oncogene is correlated with RET immunostaining of cells in sporadic medullary carcinoma","author":"Eng C","year":"1998","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"81","key":"ref73","first-page":"1619","article-title":"Somatic mutations of the RET proto-oncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence","author":"Romei C","year":"1996","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"81","key":"ref74","first-page":"2041","article-title":"RET proto-oncogene point mutations in sporadic neuroendocrine tumors","author":"Komminoth P","year":"1996","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"376","key":"ref75","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET associated with multiple endocrine neoplasia sporadic medullary thyroid carcinoma","author":"Hofstra RMW","year":"1994","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"91","key":"ref76","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation kinase catalytic domain of the RET protooncogene associated with multiple endocrine neoplasia type","author":"Carlson K M","year":"1994","journal-title":"Natl Acad Sci USA"},{"issue":"12","key":"ref77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/gcc.2870120308","article-title":"Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma","author":"Eng C","year":"1995","journal-title":"Genes Chrom Cancer"},{"issue":"69","key":"ref78","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7","article-title":"Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene","author":"Fink M","year":"1996","journal-title":"Int J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0020-7136","issn-type":"print"},{"issue":"3","key":"ref79","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/3.10.1895","article-title":"RET protooncogene mutations in inherited and sporadic medullary thyroid cancer","author":"Blaugrund JE","year":"1994","journal-title":"Hum Mol Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0964-6906","issn-type":"print"},{"issue":"56","key":"ref80","first-page":"1241","article-title":"Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma","author":"Marsh DJ","year":"1996","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"80","key":"ref81","first-page":"3088","article-title":"Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas","author":"Zedenius J","year":"1995","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/thy.1996.6.115","article-title":"RET mutation screening in MEN 2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma","author":"Jhiang SM","year":"1996","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"18","key":"ref83","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.onc.1202418","article-title":"Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation","author":"Gimm O","year":"1999","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"55","key":"ref84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2265.2001.01328.x","article-title":"Germline sequence variant S836S in the RET proto-onogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the spanish population","author":"Ruiz A","year":"2001","journal-title":"Clin Endocrinol"},{"issue":"36","key":"ref85","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmg.36.10.771","article-title":"Specific polymorphisms in the RET Proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression","author":"Borrego S","year":"1999","journal-title":"J Med Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0022-2593","issn-type":"print"},{"issue":"35","key":"ref86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3468(00)80031-7","article-title":"Incidence of RET mutations in patients with Hirschsprung\u2019s disease","author":"Sancandi M","year":"2000","journal-title":"J Pediatr Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3468","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v49n5\/a13v49n5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:21:59Z","timestamp":1736274119000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302005000500013&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0004-27302005000500013"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302005000500013","relation":{},"ISSN":["0004-2730"],"issn-type":[{"type":"electronic","value":"0004-2730"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}